Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aisylu S. Kadyrova"'
Autor:
Rawdah Karwt, Oksana V. Bondar, Mikhail V. Pugachev, Tharaa Mohammad, Aisylu S. Kadyrova, Roman S. Pavelyev, Saleh Alrhmoun, Oleg I. Gnezdilov, Yurii G. Shtyrlin
Publikováno v:
Life, Vol 14, Iss 3, p 282 (2024)
Doxorubicin (DOX) is a prevalent anticancer agent; however, it is unfortunately characterized by high cardiotoxicity, myelosuppression, and multiple other side effects. To overcome DOX limitations, two novel pyridoxine-derived doxorubicin derivatives
Externí odkaz:
https://doaj.org/article/19a0a7cc9a334ce0b42a267d70809ced
Autor:
Karwt, Rawdah1 (AUTHOR) pugachev.mihail@gmail.com, Bondar, Oksana V.1 (AUTHOR) rawdahkarwt@gmail.com, Pugachev, Mikhail V.1 (AUTHOR), Mohammad, Tharaa1 (AUTHOR), Kadyrova, Aisylu S.1 (AUTHOR), Pavelyev, Roman S.1 (AUTHOR), Alrhmoun, Saleh1 (AUTHOR), Gnezdilov, Oleg I.1 (AUTHOR), Shtyrlin, Yurii G.1 (AUTHOR) rawdahkarwt@gmail.com
Publikováno v:
Life (2075-1729). Mar2024, Vol. 14 Issue 3, p282. 27p.
Publikováno v:
Cancer Weekly; 4/11/2024, p257-257, 1p